Forcing Vaccination on Every Child Undermines Civil Liberties

Forcing Vaccination on Every Child Undermines Civil Liberties

The author's son Chris, at two years old in the summer of 1980, before his 4th DPT shot.

(Courtesy Fisher)


Keep Reading Keep Reading
Barbara Loe Fisher
Author and human rights activist Barbara Loe Fisher is co-founder and president of the non-profit National Vaccine Information Center established in 1982 to prevent vaccine injuries and deaths through public education. She is co-author of the 1985 book DPT: A Shot in the Dark, author of A Guide to Reforming Vaccine Policy and Law, founder and executive editor of the online journal newspaper, The Vaccine Reaction, and a video blog commentator on NVIC.org. She helped secure safety provisions in the 1986 National Childhood Vaccine Injury Act and has testified in Congress and state legislatures. She served on the National Vaccine Advisory Committee; Institute of Medicine Vaccine Safety Forum; the FDA Vaccines and Related Biological Products Advisory Committee and Vaccine Policy Analysis Collaborative. She has discussed vaccine science, policy and law on CBS, ABC, NBC, Fox, NPR and in USA Today, Washington Post, New York Times and many public forums.
Hidden figures: Five black women that changed science forever

Dr. May Edward Chinn, Kizzmekia Corbett, PhD., and Alice Ball, among others, have been behind some of the most important scientific work of the last century.


Keep Reading Keep Reading
Sarah Watts

Sarah Watts is a health and science writer based in Chicago.

natural killer cell
NIAID, CC BY 2.0 <https://creativecommons.org/licenses/by/2.0>, via Wikimedia Commons

On today’s episode of Making Sense of Science, I’m honored to be joined by Dr. Paul Song, a physician, oncologist, progressive activist and biotech chief medical officer. Through his company, NKGen Biotech, Dr. Song is leveraging the power of patients’ own immune systems by supercharging the body’s natural killer cells to make new treatments for Alzheimer’s and cancer.

Whereas other treatments for Alzheimer’s focus directly on reducing the build-up of proteins in the brain such as amyloid and tau in patients will mild cognitive impairment, NKGen is seeking to help patients that much of the rest of the medical community has written off as hopeless cases, those with late stage Alzheimer’s. And in small studies, NKGen has shown remarkable results, even improvement in the symptoms of people with these very progressed forms of Alzheimer’s, above and beyond slowing down the disease.

Keep Reading Keep Reading
Matt Fuchs
Matt Fuchs is the host of the Making Sense of Science podcast and served previously as the editor-in-chief of Leaps.org. He writes as a contributor to the Washington Post, and his articles have also appeared in the New York Times, WIRED, Nautilus Magazine, Fortune Magazine and TIME Magazine. Follow him @fuchswriter.